New agents within the preoperative chemotherapy of non-small cell lung cancer.
- 1 December 2001
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 34, S159-S163
- https://doi.org/10.1016/s0169-5002(01)00362-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Gemcitabine and Cisplatin as Induction Regimen for Patients With Biopsy-Proven Stage IIIA N2 Non–Small-Cell Lung Cancer: A Phase II Study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955)Journal of Clinical Oncology, 2000
- Preoperative treatment with cisplatin-gemcitabine in locally advanced nsclc: Survival, toxicity and salvage surgeryEuropean Journal Of Cancer, 1999
- Revisions in the International System for Staging Lung CancerChest, 1997
- The messages from recently completed surgical trials on lung cancerEuropean Journal of Surgical Oncology, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Results of cancer and leukemia group B protocol 8935The Journal of Thoracic and Cardiovascular Surgery, 1995
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1994
- A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung CancerNew England Journal of Medicine, 1994
- Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patientsThe Annals of Thoracic Surgery, 1993
- Randomized trial of neoadjuvant therapy for lung cancer: Interim analysisThe Annals of Thoracic Surgery, 1992